269 related articles for article (PubMed ID: 28283826)
1. Genetic polymorphism of MTHFR C677T with preterm birth and low birth weight susceptibility: a meta-analysis.
Wu H; Zhu P; Geng X; Liu Z; Cui L; Gao Z; Jiang B; Yang L
Arch Gynecol Obstet; 2017 May; 295(5):1105-1118. PubMed ID: 28283826
[TBL] [Abstract][Full Text] [Related]
2. Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis.
Cao Y; Xu J; Zhang Z; Huang X; Zhang A; Wang J; Zheng Q; Fu L; Du J
Gene; 2013 Feb; 514(2):105-11. PubMed ID: 23201418
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
Bai R; Liu W; Zhao A; Zhao Z; Jiang D
Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
[TBL] [Abstract][Full Text] [Related]
4. Mother's and child's methylenetetrahydrofolate reductase C677T polymorphism is associated with preterm delivery and low birth weight.
Chen DF; Hu YH; Yang F; Wu BY; Chen L; Fang ZA; Wang LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):248-53. PubMed ID: 15205693
[TBL] [Abstract][Full Text] [Related]
5. Association of methylenetetrahydrofolate reductase (
Yang R; Pu D; Tan R; Wu J
Arch Endocrinol Metab; 2022 Sept 08; 66(4):551-581. PubMed ID: 35758831
[TBL] [Abstract][Full Text] [Related]
6. Interaction effects of MTHFR C677T and A1298C polymorphisms with maternal glycated haemoglobin levels on adverse birth outcomes.
Wu W; Luo D; Ji C; Diao F; Wu L; Ruan X; Gu C; Luo M
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3794. PubMed ID: 38517730
[TBL] [Abstract][Full Text] [Related]
7. Association between
Tan X; Chen H
Front Endocrinol (Lausanne); 2023; 14():1273218. PubMed ID: 37964957
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the relationship between methylenetetrahydrofolate reductase C677T and A1298C polymorphism and venous thromboembolism in the Caucasian and Asian.
Gao M; Feng N; Zhang M; Ti X; Zuo X
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32614041
[TBL] [Abstract][Full Text] [Related]
9. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies.
Yan L; Zhao L; Long Y; Zou P; Ji G; Gu A; Zhao P
PLoS One; 2012; 7(10):e41689. PubMed ID: 23056169
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies.
Liang H; Yan Y; Li T; Li R; Li M; Li S; Qin X
Tumour Biol; 2014 Feb; 35(2):1695-701. PubMed ID: 24078451
[TBL] [Abstract][Full Text] [Related]
11. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
Ma C; Liu Y; Zhang W; Liu P
Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
Ren A; Wang J
Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians.
Zhong S; Yang JH; Liu K; Jiao BH; Chang ZJ
Tumour Biol; 2012 Dec; 33(6):2041-51. PubMed ID: 22890827
[TBL] [Abstract][Full Text] [Related]
14. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase C677T polymorphism and congenital heart disease: a meta-analysis.
Nie Y; Gu H; Gong J; Wang J; Gong D; Cong X; Chen X; Hu S
Clin Chem Lab Med; 2011 Dec; 49(12):2101-8. PubMed ID: 21793799
[TBL] [Abstract][Full Text] [Related]
16. Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.
Khandanpour N; Willis G; Meyer FJ; Armon MP; Loke YK; Wright AJ; Finglas PM; Jennings BA
J Vasc Surg; 2009 Mar; 49(3):711-8. PubMed ID: 19157768
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
18. Association of C677T and A1298C polymorphisms of the MTHFR gene with maternal risk for Down syndrome: A meta-analysis of case-control studies.
Ginani CTA; da Luz JRD; de Medeiros KS; Sarmento ACA; Coppedè F; das Graças Almeida M
Mutat Res Rev Mutat Res; 2023; 792():108470. PubMed ID: 37689109
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.
Long S; Yang X; Liu X; Yang P
PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018
[TBL] [Abstract][Full Text] [Related]
20. Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for Down syndrome offspring: a meta-analysis.
Wu X; Wang X; Chan Y; Jia S; Luo Y; Tang W
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):154-9. PubMed ID: 23295071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
